EP14.01-006 CeLEBrATE: Phase II trial of CarbopLatin, Etoposide, Bevacizumab and Atezolizumab in Patients with exTEnsive-Stage SCLC-GOIRC-01-2019

Autor:	Andrini, E. 1, Lamberti, G. 1, Mazzoni, F. 2, Riccardi, F. 3, Bonetti, A. 4, Follador, A. 5, Giardina, D. 6, Genova, C. 7, 8, Guaitoli, G. 9, Frassoldati, A. 10, Brighenti, M. 11, Colantonio, I. 12, Pasello, G. 13, 14, Ficorella, C. 15, Cinieri, S. 16, Tiseo, M. 17, Gelsomino, F. 18, Tognetto, M. 19, Rihawi, K. 18, Ardizzoni, A. 1
Zdroj:	In Journal of Thoracic Oncology September 2022 17(9) Supplement:S528-S529
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu